Antibacterial Activity of Some Plant Extracts Against Extended-Spectrum Beta-Lactamase Producing Escherichia coli Isolates

被引:27
|
作者
Saeidi, Saeide [1 ]
Boroujeni, Negar Amini [2 ]
Ahmadi, Hassan [1 ]
Hassanshahian, Mehdi [3 ]
机构
[1] Zabol Univ, Agr Biotechnol Res Inst, Zabol, Iran
[2] Islamic Azad Univ, Sci & Res Branch, Dept Microbiol, Kerman, Iran
[3] Shahid Bahonar Univ, Dept Biol, Fac Sci, Kerman, Iran
关键词
Escherichia coli; Plant Extract; Urinary Tract; PEGANUM-HARMALA; ANTIMICROBIAL ACTIVITY; MYRTUS-COMMUNIS; CHEMICAL-COMPOSITION; MARRUBIUM-VULGARE; CUMINUM-CYMINUM; ESSENTIAL OILS; L; BACTERIA; INHIBITORS;
D O I
10.5812/jjm.15434
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The extended-spectrum beta-lactamase (ESBL) -producing Escherichia coli isolates make many serious infections, especially urinary tract infections. Objectives: The purpose of this study was to determine the antibacterial activities of some natural plant extracts against ESBL-producing E. coli isolates, which harbor the TEM gene in urine samples of the patients who have urinary tract infections. Materials and Methods: Evaluation has to be exactly determined for both methods of disk diffusion test and polymerase chain reaction (PCR), separately. We evaluated 120 strains of E. coli isolates from the urine culture of the patients in Boo-Ali Hospital (Zahedan, southeastern Iran) who were suffering from urinary tract infections. The ESBL-producing E. coli isolates were evaluated by disk diffusion test and PCR through TEM gene detection. The minimal inhibitory concentration (MIC) of commonly used antibiotics including ceftazidime, ceftriaxon, amikacin, gentamicin and ciprofloxacin along with the MIC of the alcoholic extract of different natural plants including Myrtus communis L (Myrtaceae), Amaranthus retraflexus (Amaranthaceae), Cyminum cuminum L (Apiaceae), Marrubium vulgare (Laminaceae) and Peganum. harmala (Zygrophyllaceae) against the ESBL-producing E. coli isolates, which harbor the TEM genes, were determined using the microdulition method. Results: Results of this study showed that in disk diffusion method, 80 samples of E. coli produced ESBLs. In PCR method, the TEM gene distribution in the isolated ESBL-producing organisms was 50 (41.6%). Amikacin was the most effective anti-bacterial agent and ciprofloxacin was the least effective against E. coli isolates. All the natural plant extracts mentioned above, especially P. harmala, were effective against the selected isolates of ESBL-producing E. coli. The most frequent ESBL rate producing E. coli isolates (32 out of 50) had MIC of 2.5 mg/mL in ethanol extract of P. harmala. Conclusions: The alcoholic extract of P. harmala was very effective against the selected ESBL-producing E. coli isolates harboring the TEM gene. Therefore, it could be suggested as an antibacterial agent in the future. More researches are necessary for detecting the mechanism of this plant's behavior and its pharmacological effects.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli
    Sorlozano, Antonio
    Gutierrez, Jose
    Romero, Jose Maria
    Luna, Juan de Dios
    Damas, Miguel
    Pidrola, Gonzalo
    JOURNAL OF BASIC MICROBIOLOGY, 2007, 47 (05) : 413 - 416
  • [2] Occurrence of extended-spectrum beta-lactamase producing escherichia coli in groundwater
    Adiba, Farah
    Naufal Prakosa, Bima Rajendra
    Awaliyah, Ananda Rabiatul
    Heruputri, Nindya Vidiasty
    Kasuga, Ikuro
    Priadi, Cindy Rianti
    Rahmatika, Iftita
    7TH ENVIRONMENTAL TECHNOLOGY AND MANAGEMENT CONFERENCE, ETMC 2023, 2024, 485
  • [3] Investigation of Beta-Lactamase Genes and Clonal Relationship Among the Extended-Spectrum Beta-Lactamase Producing Nosocomial Escherichia coli Isolates
    Gorgec, Sunduz
    Kuzucu, Cigdem
    Otlu, Baris
    Yetkin, Funda
    Ersoy, Yasemin
    MIKROBIYOLOJI BULTENI, 2015, 49 (01): : 15 - 25
  • [4] Extended-spectrum beta-lactamase escherichia coli pneumonia
    Khalafi, S.
    Vazquez, A. De La Rosa
    Dihowm, F.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S97 - S97
  • [5] Prevalence and Antimicrobial Susceptibility of Extended-Spectrum Beta-Lactamase Producing Urinary Isolates of Escherichia Coli in Outpatients
    Markovic, Tatjana
    Jeinic, Ljiljana
    Smitran, Aleksandra
    Petkovic, Miroslav
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (11-12) : 775 - 779
  • [6] A Case Report of Sepsis by Extended-Spectrum beta-Lactamase Producing Escherichia Coli
    Lee, Seung Beom
    Kim, Choon Ok
    Kang, Hee Cheol
    KOREAN JOURNAL OF FAMILY MEDICINE, 2010, 31 (05): : 384 - 389
  • [7] ANTIBACTERIAL ACTIVITY OF NIGELLA SATIVA EXTRACTS AGAINST EXTENDED SPECTRUM B-LACTAMASE PRODUCING ESCHERICHIA COLI ISOLATES
    Parveen, W.
    Subhashini, A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (08): : 3825 - 3830
  • [8] Clonal diversity of extended-spectrum beta-lactamase producing Escherichia coli isolates in fecal samples of wild animals
    Cristovao, Filipe
    Andrea Alonso, Carla
    Igrejas, Gilberto
    Sousa, Margarida
    Silva, Vanessa
    Pereira, Jose Eduardo
    Lozano, Carmen
    Cortes-Cortes, Gerardo
    Torres, Carmen
    Poeta, Patricia
    FEMS MICROBIOLOGY LETTERS, 2017, 364 (05)
  • [9] Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia
    R. Ben Sallem
    K. Ben Slama
    V. Estepa
    A. Jouini
    H. Gharsa
    N. Klibi
    Y. Sáenz
    F. Ruiz-Larrea
    A. Boudabous
    C. Torres
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 1511 - 1516
  • [10] Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia
    Ben Sallem, R.
    Ben Slama, K.
    Estepa, V.
    Jouini, A.
    Gharsa, H.
    Klibi, N.
    Saenz, Y.
    Ruiz-Larrea, F.
    Boudabous, A.
    Torres, C.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (07) : 1511 - 1516